| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2972152 | The Journal of Heart and Lung Transplantation | 2009 | 6 Pages |
Abstract
Despite early diagnosis and prompt treatment, acute cellular rejection remains an independent risk factor for the development of BOS after adjusting for the confounding of post-transplant baseline FEV1.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Christopher M. MD, Martin MD, PhD, Jørn MD, PhD, Jann MD, PhD, Claus B. MD, PhD, Daniel MD, PhD, Thomas DSci, PhD,